Vanta Bioscience
Vanta Bioscience (VANTABIO) share price was ₹20.40 at the 16 Oct 2026 close; market capitalisation ₹14.50 Cr; sector Healthcare. The share price fell 20.2% over the year to 16 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹1.51 Cr, against ₹0.33 Cr a year earlier and net profit was ₹1.93 Cr, against −₹1.37 Cr a year earlier (compared with Mar 2025). Promoters held 72.81% of Vanta Bioscience in Sep 2026, unchanged from Mar 2026.
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of 16 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Healthcare Technology › Healthcare Research, Analytics & Technology
| ₹407.05 | 74.14 | 16,431 Cr | 3.38 | 0.34% | 6.54% | 8.35% | 3,613 Cr | 221 Cr | |
| ₹597.25 | 35.85 | 14,392 Cr | 4.59 | 0.38% | 12.78% | 15.40% | 3,892 Cr | 401 Cr | |
| ₹265.00 | — | 7,488 Cr | 10.94 | 0.00% | -46.73% | -45.62% | 30 Cr | -353 Cr | |
| ₹514.80 | 28.84 | 2,301 Cr | 5.04 | 0.39% | 12.83% | 16.36% | 336 Cr | 80 Cr | |
| ₹119.23 | 8.96 | 530 Cr | 1.26 | 0.47% | 9.14% | 11.73% | 441 Cr | 49 Cr | |
| ₹10.70 | 12.30 | 158 Cr | 5.10 | 0.00% | 13.73% | 15.37% | 100 Cr | 13 Cr | |
| — | — | 15 Cr | 0.69 | 0.00% | -351.27% | -14.43% | 9 Cr | -4 Cr | |
| Median 7 companies | ₹336.03 | 28.84 | 2,301 Cr | 4.59 | 0.34% | 9.14% | 11.73% | 336 Cr | 49 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
2- Company has reduced debt.
- Stock is trading at 0.69 times its book value
Weaknesses
6- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -28.6% over past five years.
- Company has a low return on equity of -15.6% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 513 days.
- Working capital days have increased from -636 days to 435 days
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 91.39% · Mar 2026
Quarterly Results
| Particulars | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 6.81 | 5.28 | 4.76 | 5.38 | 4.31 | 2.82 | 3.45 | 6.18 | 3.55 | 1.03 | 0.33 | 0.3 | 1.51 |
| Expenses | 4.61 | 3.5 | 2.58 | 3.89 | 2.33 | 3.37 | 5.3 | 4.12 | 4.3 | 1.42 | 2.01 | 0.67 | 0.13 |
| Operating Profit | 2.2 | 1.78 | 2.18 | 1.49 | 1.98 | -0.55 | -1.85 | 2.06 | -0.75 | -0.39 | -1.68 | -0.37 | 1.38 |
| OPM % | 32.31% | 33.71% | 45.8% | 27.7% | 45.94% | -19.5% | -53.62% | 33.33% | -21.13% | -37.86% | -509.09% | -123.33% | 91.39% |
| Other Income | 0.11 | 0 | 0.03 | 0.02 | 0.4 | 0.01 | 0.68 | 0.03 | 0.08 | 0.04 | 0.04 | 0 | 0.16 |
| Interest | 0.98 | 1.01 | 1.13 | 1.14 | 1.2 | 2.48 | 3.4 | 2.85 | 2.9 | 2.14 | -0.06 | 0.88 | -0.11 |
| Depreciation | 0.78 | 0.61 | 0.65 | 0.66 | 0.66 | 1.31 | 1.36 | 1.54 | 2.95 | 1.69 | -0.17 | 0.61 | -0.23 |
| PBT | 0.55 | 0.16 | 0.43 | -0.29 | 0.52 | -4.33 | -5.93 | -2.3 | -6.52 | -4.18 | -1.41 | -1.86 | 1.88 |
| Tax % | 16.36% | 68.75% | 9.3% | -106.9% | 13.46% | 2.08% | 1.52% | -0.87% | -3.07% | -1.2% | -2.13% | -2.69% | -2.66% |
| Net Profit | 0.46 | 0.06 | 0.39 | 0.02 | 0.07 | -2.56 | -3.92 | -0.54 | -1.78 | -2.07 | -1.37 | -1.82 | 1.93 |
| EPS (₹) | 0.73 | 0.1 | 0.62 | 0.03 | 0.11 | -4.06 | -6.21 | -0.86 | -2.82 | -3.28 | -2.17 | -2.56 | 2.71 |
Profit & Loss
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.08 | 13.75 | 9.82 | 9.4 | 5.83 | 9.72 | 1.96 | 1.82 |
| Expenses | 8.81 | 9.38 | 5.87 | 5.93 | 8.22 | 8.41 | 6.21 | 0.8 |
| Operating Profit | 3.27 | 4.37 | 3.95 | 3.47 | -2.39 | 1.31 | -4.25 | 1.02 |
| OPM % | 27.07% | 31.78% | 40.22% | 36.91% | -40.99% | 13.48% | -216.84% | 56.04% |
| Other Income | 0.23 | 0.11 | 0.03 | 0.42 | 0.69 | 0.11 | 0.11 | 0.16 |
| Interest | 1.69 | 1.95 | 2.14 | 2.35 | 5.89 | 5.75 | 4.07 | 0.78 |
| Depreciation | 0.71 | 1.19 | 1.25 | 1.32 | 2.67 | 4.5 | 4.42 | 0.39 |
| PBT | 1.1 | 1.34 | 0.59 | 0.22 | -10.26 | -8.83 | -12.63 | 0.01 |
| Tax % | 36.36% | 24.63% | 23.73% | 40.91% | 1.75% | -2.49% | 5.23% | -900% |
| Net Profit | 0.7 | 1.01 | 0.45 | 0.14 | -10.44 | -8.61 | -13.29 | 0.11 |
| EPS (₹) | 1.11 | 1.58 | 0.71 | 0.14 | -10.27 | -3.68 | -7.56 | 0.15 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.31 | 6.31 | 6.31 | 6.31 | 6.31 | 6.31 | 6.31 | 7.11 |
| Reserves | 15.94 | 17.16 | 17.61 | 17.7 | 11.2 | 8.89 | 4.11 | 14.06 |
| Borrowings | 13.25 | 17.37 | 35.97 | 44.86 | 57.16 | 60.96 | 70.09 | 38.08 |
| Other Liabilities | 3.51 | 7.74 | 9.74 | 12.53 | 10.04 | 9.24 | 5.37 | 6.85 |
| Total Liabilities | 39.01 | 48.58 | 69.63 | 81.4 | 84.71 | 85.4 | 85.88 | 66.1 |
| Fixed Assets | 17.9 | 20.76 | 29.39 | 36.12 | 57.22 | 54.15 | 55.5 | 48.08 |
| CWIP | 3.7 | 7 | 19.34 | 28.47 | 10.6 | 12.53 | 13.47 | 0 |
| Investments | 1.95 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
| Other Assets | 15.46 | 20.82 | 20.9 | 16.81 | 16.89 | 18.72 | 16.91 | 15.02 |
| Total Assets | 39.01 | 48.58 | 69.63 | 81.4 | 84.71 | 85.4 | 85.88 | 66.1 |
Cash Flow
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | -1.04 | 2.34 | 6.97 | 5.28 | -0.63 | 2.68 | -2.41 | -5.22 |
| Investing | -5.73 | -7.59 | -22.3 | -17.24 | -5.91 | -3.31 | -6.69 | -6.87 |
| Financing | 9.94 | 2.17 | 17.78 | 9.53 | 6.41 | 0.69 | 9.16 | 12.08 |
| Net Cash Flow | 3.18 | -3.07 | 2.46 | -2.43 | -0.13 | 0.06 | 0.06 | -0.01 |
| Free Cash Flow | -3.52 | -5.01 | -15.23 | -11.9 | -6.54 | -0.63 | -9.1 | -12.09 |
| CFO/OP | -32 | 54 | 176 | 152 | 26 | 205 | 57 | -512 |
Ratios
| Particulars | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47.14 | 36.9 | 74.71 | 43.88 | 123 | 118 | 466 | 513 |
| Inventory Days | — | — | — | — | — | — | 2,400 | — |
| Days Payable | — | — | — | — | — | — | 1,821 | — |
| Cash Conversion Cycle | 47.14 | 36.9 | 74.71 | 43.88 | 123 | 118 | 1,044 | 513 |
| Working Capital Days | 261 | 260 | 91.06 | -135 | -163 | -217 | -2,127 | 435 |
| ROCE % | — | 8.35% | 5.21% | 3.77% | -5.82% | -4.16% | -11.58% | 1.19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vanta Bioscience insights
57 extracted metrics + investor summaries across FY17–FY26.
Documents
Frequently Asked Questions about Vanta Bioscience
What does Vanta Bioscience Ltd do?
Where is Vanta Bioscience Ltd (VANTABIO) listed?
Which sector does Vanta Bioscience Ltd belong to?
What is the market capitalisation of Vanta Bioscience Ltd?
What is the 52-week high and low of Vanta Bioscience Ltd?
What is the Return on Equity (ROE) of Vanta Bioscience Ltd?
Company Information
Incorporated in 2016, Vanta Bioscience Ltd is a full-service preclinical contract research organisation. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540729.md for Vanta Bioscience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.